216 related articles for article (PubMed ID: 33856609)
1. Ranitidine Use and Gastric Cancer Among Persons with Helicobacter pylori.
Kumar S; Goldberg DS; Kaplan DE
Dig Dis Sci; 2022 May; 67(5):1822-1830. PubMed ID: 33856609
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.
Kumar S; Metz DC; Ellenberg S; Kaplan DE; Goldberg DS
Gastroenterology; 2020 Feb; 158(3):527-536.e7. PubMed ID: 31654635
[TBL] [Abstract][Full Text] [Related]
3. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for
Cheung KS; Chan EW; Wong AYS; Chen L; Wong ICK; Leung WK
Gut; 2018 Jan; 67(1):28-35. PubMed ID: 29089382
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
5. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
Gisbert JP; Gonzalez L; Calvet X
Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
[TBL] [Abstract][Full Text] [Related]
9. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Gisbert JP; Carpio D; Marcos S; Gisbert JL; García Grávalos R; Pajares JM
Eur J Gastroenterol Hepatol; 2000 May; 12(5):489-95. PubMed ID: 10833090
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
[TBL] [Abstract][Full Text] [Related]
11. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
14. The Effect of
Song JH; Yang SY; Lim JH; Choi JM; Kim SG
Korean J Gastroenterol; 2017 Jul; 70(1):27-32. PubMed ID: 28728313
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
Ocaña Andrade E; Espinosa Soberanes JA; Mares Zambrano MA; Rosete Reyes A
Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667
[TBL] [Abstract][Full Text] [Related]
16. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
[TBL] [Abstract][Full Text] [Related]
17. Oesophageal and proximal gastric adenocarcinomas are rare after detection of Helicobacter pylori infection.
Kumar S; Metz DC; Ginsberg GG; Kaplan DE; Goldberg DS
Aliment Pharmacol Ther; 2020 Apr; 51(8):781-788. PubMed ID: 32133681
[TBL] [Abstract][Full Text] [Related]
18. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
Gisbert JP; Marcos S; Gisbert JL; Pajares JM
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1303-7. PubMed ID: 11692055
[TBL] [Abstract][Full Text] [Related]
20. Acid suppression with ranitidine plus oral triple therapy improves ulcer healing but not Helicobacter pylori eradication.
Magalhaes AF; Macedo C; Hauck JR; Carvalhaes A; De Nucci G; Magna LA; Pedrazzoli J
Hepatogastroenterology; 1998; 45(24):2161-4. PubMed ID: 9951885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]